FT Options’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,240	Closed	-$62K	–	72
2017 Q2	$62K	Buy	+11,240	New	+$62K	0.11%	48
2017 Q1	–	Hold	0	–	–	–	93
2016 Q1	–	Sell	-39,600	Closed	-$409K	–	80
2015 Q4	$409K	Buy	+39,600	New	+$409K	0.3%	49